This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Dec;154(6):269-71.

doi: 10.1016/j.trsl.2009.09.010. Epub 2009 Oct 14.

Getting personal: the promises and pitfalls of personalized medicine

Jeffrey Laurence¹

Affiliations

Affiliation

¹ Division of Hematology/Oncology, Weill Cornell Medical College, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA. jlaurenc@med.cornell.edu

PMID: 19931191
DOI: 10.1016/j.trsl.2009.09.010

Getting personal: the promises and pitfalls of personalized medicine

Jeffrey Laurence. Transl Res. 2009 Dec.

. 2009 Dec;154(6):269-71.

doi: 10.1016/j.trsl.2009.09.010. Epub 2009 Oct 14.

Author

Jeffrey Laurence¹

Affiliation

¹ Division of Hematology/Oncology, Weill Cornell Medical College, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA. jlaurenc@med.cornell.edu

PMID: 19931191
DOI: 10.1016/j.trsl.2009.09.010

No abstract available

PubMed Disclaimer

Similar articles

Getting personal: the promises and potential pitfalls of personalized medicine.
Ozer BH. Ozer BH. Virtual Mentor. 2012 Aug 1;14(8):601-3. doi: 10.1001/virtualmentor.2012.14.8.fred1-1208. Virtual Mentor. 2012. PMID: 23351312 No abstract available.
Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S, Desai MC. Chackalamannil S, et al. Curr Opin Drug Discov Devel. 2009 Jul;12(4):443-5. Curr Opin Drug Discov Devel. 2009. PMID: 19562640
Getting personal. Advances in biotechnology and the promise of personalized medicine help drive record investment in 2009.
Vesely R. Vesely R. Mod Healthc. 2010 Feb 1;40(5):26-8. Mod Healthc. 2010. PMID: 20198737 No abstract available.
Personalized medicine: individualized care of cancer patients.
Ely S. Ely S. Transl Res. 2009 Dec;154(6):303-8. doi: 10.1016/j.trsl.2009.08.001. Epub 2009 Sep 1. Transl Res. 2009. PMID: 19931196 Review.
Drug development for orphan diseases in the context of personalized medicine.
Brewer GJ. Brewer GJ. Transl Res. 2009 Dec;154(6):314-22. doi: 10.1016/j.trsl.2009.03.008. Epub 2009 Apr 23. Transl Res. 2009. PMID: 19931198 Review.

See all similar articles

Cited by

Minimum information required for a DMET experiment reporting.
Kumuthini J, Mbiyavanga M, Chimusa ER, Pathak J, Somervuo P, Van Schaik RH, Dolzan V, Mizzi C, Kalideen K, Ramesar RS, Macek M, Patrinos GP, Squassina A. Kumuthini J, et al. Pharmacogenomics. 2016 Sep;17(14):1533-45. doi: 10.2217/pgs-2016-0015. Epub 2016 Aug 22. Pharmacogenomics. 2016. PMID: 27548815 Free PMC article.
Community engagement in biobanking: Experiences from the eMERGE Network.
Lemke AA, Wu JT, Waudby C, Pulley J, Somkin CP, Trinidad SB. Lemke AA, et al. Genom Soc Policy. 2010;6(3):50. doi: 10.1186/1746-5354-6-3-50. Genom Soc Policy. 2010. PMID: 22962560 Free PMC article.
Conceptual and terminological confusion around personalised medicine: a coping strategy.
De Grandis G, Halgunset V. De Grandis G, et al. BMC Med Ethics. 2016 Jul 18;17(1):43. doi: 10.1186/s12910-016-0122-4. BMC Med Ethics. 2016. PMID: 27431285 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources